Death receptor 6 (DR6), a downstream target of the Wnt/β-catenin pathway, is highly expressed in the brain vasculature but significantly reduced in BECs of the APP/PS1 murine model of AD. Here, TNFRSF21 is linked to Alzheimer disease.